Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience.
about
Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreasConcomitant endometrial and pancreatic cancers.ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CTPancreatic fistulae after pancreatic resections for neuroendocrine tumours compared with resections for other lesionsClinicopathological features of small nonfunctioning pancreatic neuroendocrine tumorsTreatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)The Diagnosis and Treatment of Bronchopulmonary CarcinoidLymph nodes and survival in pancreatic neuroendocrine tumors.Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review.Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated?A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survivalPancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness.Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review.Surgical management of pancreatic neuroendocrine tumors.Pancreatic neuroendocrine and carcinoid tumors: what's new, what's old, and what's different?Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors.Consensus guidelines for the management and treatment of neuroendocrine tumors.Laparoscopic resection of pancreatic neuroendocrine tumors.Outcomes of 101 Consecutive Surgical Resections of Gastroenteropancreatic Neuroendocrine Tumours (GEPNETs) at Tata Memorial Hospital: a Referral Bias for Nonfunctional Duodenopancreatic Tumours and the Need for Greater Awareness of GEPNETs as a DistImaging of secretory tumors of the gastrointestinal tract.Pancreatic Neuroendocrine Tumors (panNETs): Analysis of Overall Survival of Nonsurgical Management Versus Surgical Resection.Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors.Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors.Synchronous resection of primary and liver metastases for neuroendocrine tumors.Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems.Tumors of the Pancreatic Body and Tail.Prognostic significance of cytokeratin 19 expression in pancreatic neuroendocrine tumor: A meta-analysis.Basing treatment strategy for non-functional pancreatic neuroendocrine tumors on tumor size.Locally Recurrent Well-Differentiated Nonfunctioning Pancreatic Neuroendocrine Tumor Requiring Re-excision Including Portal Vein Resection.Multimodality Management of "Borderline Resectable" Pancreatic Neuroendocrine Tumors: Report of a Single-Institution Experience.Laparoscopic surgery for pancreatic neoplasms: the European association for endoscopic surgery clinical consensus conference.Expression of CK19 and KIT in resectable pancreatic neuroendocrine tumors.Prognostic factors and survival in patients with neuroendocrine tumors of the pancreas.
P2860
Q26752757-D790ABBD-D15E-4636-B1B6-9CF40C700677Q33763759-ED44957C-84BD-4FA4-BB4F-D84057AB25B7Q34248466-A7D40AEE-9FAD-4FFF-993C-6E35CD13B811Q34503869-E233FF44-D0F6-40AC-8BB4-5419A285A642Q34702075-F6AD7760-B3FC-40D6-A5C1-E3209CE32D3DQ34750730-568FE444-BED1-41B9-9239-95057897672DQ35371197-C56E03D9-50FD-440C-91BB-615B14C473DCQ35760798-9FF31665-DC79-4C93-991F-0DC20D164FA3Q35916386-C21BD0C3-98A4-4347-8434-9798C1B695ACQ36250472-E4B1A76D-31AB-4FD3-A2A3-873A5755D272Q36558853-684954D2-0B73-4192-A0A7-2662485F35C7Q37056120-38D88406-3DE9-4616-ADB6-35FF59A2E676Q37175960-A2D706DD-44C6-4188-BE33-FD04D797A0C5Q37277977-43110D19-D830-4BAB-95B4-45F6E3CA5F6AQ37295241-055CC89E-21D8-4F9E-A4A0-9710621848EFQ37326199-0E62A83E-2072-48C7-B3CD-3D6B032DCB92Q37669053-97A5F6E5-2186-48DC-941A-3AA16B4E62F9Q37847859-BADBBBAD-75BB-4451-AFF5-70C6744FA324Q37933151-9F6C82BC-3690-4D95-A236-4A8A3D7AF2A3Q37995522-8BBB9C10-90D8-4D23-932A-710D77D043C4Q38038098-8E7910D7-D05F-48C7-9BEE-AC468146A354Q38099515-106929BC-4C34-4AB4-94E7-A9B1B3BC0F04Q38209925-917D0A80-2562-4A17-9561-9A824D57EA71Q38703694-A96DDACA-85C2-4FB9-88D1-C4BC6C93825AQ39017749-B948A911-44CB-4058-9250-83824EF8229BQ39159369-037449F8-D29B-4CDC-A165-CA5F02EC2AC8Q39773838-0E011A5E-90B0-4F67-8EB5-67E8EA9E3153Q40467865-A4376106-5B94-49AF-9F75-CCF3701551A4Q44323590-F9772E1D-2977-4F28-9436-570D58659DA6Q45071563-5A33D950-8B79-4267-A378-D1D64DA913D9Q46811048-2EB197B9-BC15-47AD-9E68-9ED29174A4D4Q46946845-CB2F2945-8648-4B47-90E6-5532649F7178Q47108788-CC21232F-B416-4785-8E77-EDB9ED93552FQ47175334-693E4B2D-1B89-493C-9636-51BF6FFB3600Q48263521-70B104B9-0A89-4684-8647-ABBC48A038EAQ48641659-49E7D221-2441-473C-BE88-5332A1BCF51AQ48695691-E6B02D94-911A-4416-B9AB-9C095824B27EQ50981144-FFEB4817-9EAD-4238-802F-F5D26D237D0DQ51041052-119E27DA-4D0C-431E-BE39-82E4A6DEB308
P2860
Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Aggressive surgery improves lo ...... : an institutional experience.
@en
type
label
Aggressive surgery improves lo ...... : an institutional experience.
@en
prefLabel
Aggressive surgery improves lo ...... : an institutional experience.
@en
P2093
P2860
P1433
P1476
Aggressive surgery improves lo ...... : an institutional experience.
@en
P2093
Emre F Yekebas
Helge Kleinhans
Jakob R Izbicki
Jussuf T Kaifi
Paulus G Schurr
Tim Strate
Uta Reichelt
P2860
P304
P356
10.1097/01.SLA.0000232556.24258.68
P407
P577
2007-02-01T00:00:00Z